Sodium valproate

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Sodium valproate and local guidelines before prescribing.

Anticonvulsant

Mechanism

Increases GABA, blocks sodium channels and T-type calcium channels.

Uses

Generalised and focal epilepsy, bipolar disorder (valproate semisodium), migraine prophylaxis.

Dosing

4 more dose entries from the chapters

Side effects

Weight gain, tremor, hair loss, thrombocytopenia, hepatotoxicity, pancreatitis, hyperammonaemia, teratogenic.

Interactions

Lamotrigine levels double; carbapenems reduce levels; enzyme inducers.

Contraindications and cautions

Liver disease, women of childbearing potential, mitochondrial disease

Monitoring

LFT, FBC, levels if needed

Pregnancy and breastfeeding

Contraindicated unless Pregnancy Prevention Programme criteria met

Renal and hepatic impairment

Avoid in significant hepatic dysfunction

Overdose and reversal

Naloxone sometimes; supportive

Special advice

Not for women of childbearing potential without Pregnancy Prevention Programme; check LFT and FBC.

More from the textbook: uses, cautions and other points
Where it is discussed in the book